Lyra Therapeutics (LYRA) Treasury Shares (2022 - 2025)
Quarterly Treasury Shares rose 20.88% to $51814.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51814.0 through Dec 2025, up 20.88% year-over-year, with the annual reading at $51814.0 for FY2025, 20.88% up from the prior year.
Lyra Therapeutics' Treasury Shares history spans 4 years, with the latest figure at $51814.0 for Q4 2025.
- Treasury Shares came in at $51814.0 for Q4 2025, down from $58882.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $4.7 million in Q1 2025 to a low of $28212.0 in Q4 2022.
- The 4-year median for Treasury Shares is $95426.0 (2023), against an average of $548418.8.
- Year-over-year, Treasury Shares surged 588.08% in 2023 and then crashed 93.21% in 2025.
- Lyra Therapeutics' Treasury Shares stood at $28212.0 in 2022, then skyrocketed by 272.35% to $105048.0 in 2023, then tumbled by 59.19% to $42865.0 in 2024, then grew by 20.88% to $51814.0 in 2025.
- Per Business Quant, the three most recent readings for LYRA's Treasury Shares are $51814.0 (Q4 2025), $58882.0 (Q3 2025), and $85804.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 700,000.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 34.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Lyra Therapeutics | - | - | - | 51,814.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51,814.00 |
| Dec 31, 2025 | 51,814.00 |
| Sep 30, 2025 | 58,882.00 |
| Sep 30, 2025 | 58,882.00 |
| Jun 30, 2025 | 85,804.00 |
| Jun 30, 2025 | 85,804.00 |
| Mar 31, 2025 | 4.74 Mn |
| Mar 31, 2025 | 4.74 Mn |
| Dec 31, 2024 | 42,865.00 |
| Dec 31, 2024 | 42,865.00 |
| Sep 30, 2024 | 867,472.00 |
| Sep 30, 2024 | 867,472.00 |
| Jun 30, 2024 | 867,472.00 |
| Jun 30, 2024 | 867,472.00 |
| Mar 31, 2024 | 1.06 Mn |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | 105,048.00 |
| Dec 31, 2023 | 105,048.00 |
| Sep 30, 2023 | 243,703.00 |
| Sep 30, 2023 | 243,703.00 |
| Jun 30, 2023 | 243,703.00 |
| Jun 30, 2023 | 243,703.00 |
| Mar 31, 2023 | 260,616.00 |
| Mar 31, 2023 | 260,616.00 |
| Dec 31, 2022 | 28,212.00 |
| Dec 31, 2022 | 28,212.00 |
| Sep 30, 2022 | 35,418.00 |
| Sep 30, 2022 | 35,418.00 |
| Jun 30, 2022 | 42,353.00 |
| Jun 30, 2022 | 42,353.00 |
| Mar 31, 2022 | 42,879.00 |
| Mar 31, 2022 | 42,879.00 |